相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The Association Between Mammographic Calcifications and Breast Cancer Prognostic Factors in a Population-Based Registry Cohort
Sarah J. Nyante et al.
CANCER (2017)
Epidermal growth factor is a potential biomarker for poor cetuximab response in tongue cancer cells
Anna Ansell et al.
JOURNAL OF ORAL PATHOLOGY & MEDICINE (2016)
Reduced serum levels of syndecan-1 in patients with tongue squamous cell carcinoma
Mohammad Sohrabi Shegefti et al.
LARYNGOSCOPE (2016)
Survival Rates for Breast Cancer in Iranian Patients: a Meta-Analysis
Mitra Rahimzadeh et al.
Asian Pacific Journal of Cancer Prevention (2016)
Incidence of primary breast cancer in Iran: Ten-year national cancer registry data report
Seyed Behzad Jazayeri et al.
CANCER EPIDEMIOLOGY (2015)
Syndecan-1 in Cancer: Implications for Cell Signaling, Differentiation, and Prognostication
Tunde Szatmari et al.
DISEASE MARKERS (2015)
Syndecan-1 Expression Is Associated with Tumor Size and EGFR Expression in Colorectal Carcinoma: A Clinicopathological Study of 230 Cases
Su Young Kim et al.
INTERNATIONAL JOURNAL OF MEDICAL SCIENCES (2015)
Molecular and clinical profiles of syndecan-1 in solid and hematological cancer for prognosis and precision medicine
Mohamed R. Akl et al.
ONCOTARGET (2015)
Soluble CD138/Syndecan-1 Increases in the Sera of Patients with Moderately Differentiated Bladder Cancer
Mohammad Nabi Sanaee et al.
UROLOGIA INTERNATIONALIS (2015)
Malignant calcification is an important unfavorable prognostic factor in primary invasive breast cancer
Hong Ling et al.
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY (2013)
TAZ induces growth factor-independent proliferation through activation of EGFR ligand amphiregulin
Nuo Yang et al.
CELL CYCLE (2012)
Molecular functions of syndecan-1 in disease
Yvonne Hui-Fang Teng et al.
MATRIX BIOLOGY (2012)
Non-canonical HIF-2α function drives autonomous breast cancer cell growth via an AREG-EGFR/ErbB4 autocrine loop
D. P. Stiehl et al.
ONCOGENE (2012)
Survival Rate of Breast Cancer Based on Geographical Variation in Iran, a National Study
Mohammad Movahedi et al.
IRANIAN RED CRESCENT MEDICAL JOURNAL (2012)
Sdc1 negatively modulates carcinoma cell motility and invasion
Tohru Ishikawa et al.
EXPERIMENTAL CELL RESEARCH (2010)
Breast carcinoma-rare types: review of the literature
R. Yerushalmi et al.
ANNALS OF ONCOLOGY (2009)
Syndecan-1 shedding facilitates the resolution of neutrophilic inflammation by removing sequestered CXC chemokines
Kazutaka Hayashida et al.
BLOOD (2009)
Differential roles for membrane-bound and soluble syndecan-1 (CD138) in breast cancer progression
Viktoriya Nikolova et al.
CARCINOGENESIS (2009)
Role of the Heparan Sulfate Proteoglycan Syndecan-1 (CD138) in Delayed-Type Hypersensitivity
Behzad Kharabi Masouleh et al.
JOURNAL OF IMMUNOLOGY (2009)
Functional selectivity of EGF family peptide growth factors: Implications for cancer
Kristy J. Wilson et al.
PHARMACOLOGY & THERAPEUTICS (2009)
Prognostic impact of syndecan-1 expression in invasive ductal breast carcinomas
D. Loussouarn et al.
BRITISH JOURNAL OF CANCER (2008)
The epidermal growth factor receptor family: Biology driving targeted therapeutics
M. J. Wieduwilt et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2008)
Cancer survival in five continents: a worldwide population-based study (CONCORD)
Michel P. Coleman et al.
LANCET ONCOLOGY (2008)
Uses and abuses of tumor markers in the diagnosis, monitoring, and treatment of primary and metastatic breast cancer
N. Lynn Henry et al.
ONCOLOGIST (2006)
The role of syndecans in disease and wound healing
Constance Y. Fears et al.
MATRIX BIOLOGY (2006)
Shift of syndecan-1 expression from epithelial to stromal cells during progression of solid tumours
D Mennerich et al.
EUROPEAN JOURNAL OF CANCER (2004)
Prognostic value of syndecan-1 expression in breast cancer
M Leivonen et al.
ONCOLOGY (2004)
Cleavage of syndecan-1 by membrane type matrix metalloproteinase-1 stimulates cell migration
K Endo et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
High syndecan-1 expression in breast carcinoma is related to an aggressive phenotype and to poorer prognosis
M Barbareschi et al.
CANCER (2003)
分享论文
